May 31, 2021

COVID-19 Drugs: Canadian COLCORONA Study Shows That Colchicine Can Reduce Certain Complications Of COVID-19

Posted by in category: biotech/medical

COVID-19 Drugs: Canadian researchers from the Montreal Heart Institute (MHI) and the Université de Montréal announced the clinical trial findings of the COLCORONA study (NCT04322682), which was a phase 3, randomized, double-blind, adaptive, placebo-controlled, multicentre trial of the oral anti-inflammatory medication called Colchicine on hospitalized COVID-19 patients. The stu…

Comments are closed.